TICAGRELOR PROPHARM 90 MG

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

TICAGRELOR

Pieejams no:

PROPHARM LTD

ATĶ kods:

B01AC24

Zāļu forma:

FILM COATED TABLETS

Kompozīcija:

TICAGRELOR 90 MG

Ievadīšanas:

PER OS

Receptes veids:

Required

Ražojis:

ADALVO LIMITED, MALTA

Ārstniecības joma:

TICAGRELOR

Ārstēšanas norādes:

TICAGRELOR PROPHARM is indicated for co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.

Autorizācija datums:

2023-08-06